Correlation Between Passage Bio and Viridian Therapeutics
Can any of the company-specific risk be diversified away by investing in both Passage Bio and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Passage Bio and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Passage Bio and Viridian Therapeutics, you can compare the effects of market volatilities on Passage Bio and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Passage Bio with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Passage Bio and Viridian Therapeutics.
Diversification Opportunities for Passage Bio and Viridian Therapeutics
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Passage and Viridian is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Passage Bio and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and Passage Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Passage Bio are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of Passage Bio i.e., Passage Bio and Viridian Therapeutics go up and down completely randomly.
Pair Corralation between Passage Bio and Viridian Therapeutics
Given the investment horizon of 90 days Passage Bio is expected to under-perform the Viridian Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Passage Bio is 1.01 times less risky than Viridian Therapeutics. The stock trades about -0.5 of its potential returns per unit of risk. The Viridian Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 1,976 in Viridian Therapeutics on November 2, 2024 and sell it today you would earn a total of 32.00 from holding Viridian Therapeutics or generate 1.62% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Passage Bio vs. Viridian Therapeutics
Performance |
| Timeline |
| Passage Bio |
| Viridian Therapeutics |
Passage Bio and Viridian Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Passage Bio and Viridian Therapeutics
The main advantage of trading using opposite Passage Bio and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Passage Bio position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.| Passage Bio vs. Black Diamond Therapeutics | Passage Bio vs. Revolution Medicines | Passage Bio vs. Stoke Therapeutics | Passage Bio vs. Cabaletta Bio |
| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |